These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 17907266
1. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease. Staekenborg SS, Gillissen F, Romkes R, Pijnenburg YA, Barkhof F, Scheltens P, van der Flier WM. Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266 [Abstract] [Full Text] [Related]
2. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease. Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW. Eur Neurol; 2011 Apr; 66(2):75-82. PubMed ID: 21778730 [Abstract] [Full Text] [Related]
4. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Neurology; 2005 Mar 08; 64(5):861-5. PubMed ID: 15753423 [Abstract] [Full Text] [Related]
5. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease. García-Alberca JM, Florido M, Cáceres M, Sánchez-Toro A, Lara JP, García-Casares N. Psychogeriatrics; 2019 Jan 08; 19(1):46-54. PubMed ID: 30084177 [Abstract] [Full Text] [Related]
7. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ. Brain; 2008 Dec 08; 131(Pt 12):3286-98. PubMed ID: 18927145 [Abstract] [Full Text] [Related]
8. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning. Oosterman JM, Vogels RL, van Harten B, Gouw AA, Scheltens P, Poggesi A, Weinstein HC, Scherder EJ. Brain Cogn; 2008 Nov 08; 68(2):128-33. PubMed ID: 18450353 [Abstract] [Full Text] [Related]
9. Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study. Galluzzi S, Talassi E, Belussi M, Scheltens P, van de Pol L, Nobili F, Rodriguez G, Froelich L, Damian M, Martinez-Lage P, Gomez-Isla T, Reynish E, Ousset PJ, Vellas B, Frisoni GB. Dement Geriatr Cogn Disord; 2008 Nov 08; 26(4):314-22. PubMed ID: 18841016 [Abstract] [Full Text] [Related]
10. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale. Cho H, Kwon JH, Seo HJ. Arch Gerontol Geriatr; 2009 Nov 08; 48(3):415-8. PubMed ID: 18468705 [Abstract] [Full Text] [Related]
11. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Korf ES, van Straaten EC, de Leeuw FE, van der Flier WM, Barkhof F, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund LO, Rostrup E, Schmidt R, Fazekas F, Scheltens P, LADIS Study Group. Diabet Med; 2007 Feb 08; 24(2):166-71. PubMed ID: 17257279 [Abstract] [Full Text] [Related]
13. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Schoonenboom NS, van der Flier WM, Blankenstein MA, Bouwman FH, Van Kamp GJ, Barkhof F, Scheltens P. Neurobiol Aging; 2008 May 08; 29(5):669-75. PubMed ID: 17208336 [Abstract] [Full Text] [Related]
14. White matter hyperintensities and cognitive dysfunction in Alzheimer disease. Heo JH, Lee ST, Kon Chu, Park HJ, Shim JY, Kim M. J Geriatr Psychiatry Neurol; 2009 Sep 08; 22(3):207-12. PubMed ID: 19433863 [Abstract] [Full Text] [Related]